NCT05873881View on ClinicalTrials.gov

COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Heart Failure
Interventions
DRUG

Colchicine 0.5 MG

Oral colchicine 0.5 mg daily

DRUG

Colchicine placebo

Placebo colchicine daily

DRUG

Thiamine Mononitrate 300 mg

Thiamine Mononitrate 300 mg daily

Trial Locations (1)

L8L 2X2

RECRUITING

Hamilton Health Sciences Corporation, Hamilton

Sponsors
All Listed Sponsors
collaborator

Population Health Research Institute

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Hamilton Health Sciences Corporation

OTHER

NCT05873881 - COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease | Biotech Hunter | Biotech Hunter